Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-10-11Clinical Trial Update: Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL) [NA]
Clinical trial update on immunotherapy for breast cancer-related upper extremity lymphedema (BCRL) has completed with results posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Management of Insomnia in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update on managing insomnia in breast cancer patients; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-10-04Clinical Trial Update: Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt [Phase 2, Phase 3]
A multi-phase clinical trial assessing neo-adjuvant chemotherapy followed by breast-conserving surgery in breast cancer in Upper Egypt; stat…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial [Phase 3]
A Phase 3 single-blinded randomized controlled trial evaluating tissue expander/implant reconstruction in breast cancer patients has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) [Phase 3]
Phase 3 trial evaluating talazoparib in advanced/metastatic breast cancer with BRCA mutations has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) [Phase 3]
Phase 3 trial of denosumab as adjuvant therapy in women with high-risk early breast cancer has been terminated with results posted.
-
FDA approval · 2018-10-03FDA Approved: EXEMESTANE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original application for Exemestane as a generic drug, manufactured by Zydus Pharmaceuticals USA Inc., for the treatment of…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer [NA]
Clinical trial investigating arm circumference with or without bioimpedance spectroscopy for early lymphedema detection in stage I-III breas…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Iodine Supplementation on Breast Cancer [Phase 2]
Phase 2 clinical trial investigating iodine supplementation in breast cancer patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer [Phase 2]
A Phase 2 clinical trial update investigating an aromatase inhibitor in adjuvant therapy combined with pertuzumab/trastuzumab for women with…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab, cyclophosphamide, and a vaccine therapy in high-risk or metastatic breast cancer; study completed with…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer [Phase 2]
Phase 2 trial evaluating dose-dense doxorubicin and cyclophosphamide followed by eribulin for adjuvant treatment of early-stage breast cance…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy [Phase 2]
Phase 2 clinical trial update investigating capecitabine for HER2-positive breast cancer with residual disease after preoperative chemothera…
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery [Phase 4]
Clinical trial update evaluating the effect of perioperative low-dose ketamine on postoperative recovery in breast cancer surgery (Phase 4).
-
FDA approval · 2018-09-20FDA Approved: PERJETA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for PERJETA (pertuzumab) filed by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating ipatasertib in combination with paclitaxel as neoadjuvant treatment for early-stage triple-negative breast cancer h…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer [Phase 3]
Phase 3 trial investigating estrogen priming to enhance adjuvant chemotherapy in operable breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. [Phase 3]
Phase 3 trial evaluating efficacy and safety of LEE011 (ribociclib) in men and postmenopausal women with advanced breast cancer has complete…
-
CLINICAL_TRIALS research · 2018-09-19Clinical Trial Update: PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer [Phase 2]
Phase 2 trial investigating PAM50 HER2-enriched phenotype as a predictor of response to dual HER2 blockade in HER2-positive early breast can…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy [Phase 2]
Phase 2 trial evaluating preoperative trastuzumab, pertuzumab, and letrozole in endocrine-sensitive HER2-positive, hormone receptor-positive…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer [Phase 2]
Phase 2 trial comparing neoadjuvant chemotherapy regimens (weekly paclitaxel or eribulin) followed by doxorubicin/cyclophosphamide in locall…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer [Phase 3]
Phase 3 trial investigating trastuzumab or lapatinib ditosylate in women with early breast cancer; status and results not provided here.
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women [Phase 2]
Phase 2 trial investigating letrozole with or without BYL719 or buparlisib as neoadjuvant therapy for postmenopausal women with breast cance…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses [Phase 2]
Phase 2 neoadjuvant trial of docetaxel and cyclophosphamide with pharmacokinetic and pharmacogenomic analyses for locally advanced or node-p…